#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune myositis Acute on chronic liver failure Asthma Infertility male Anaplastic large cell lymphoma T- and null-cell types Alveolar rhabdomyosarcoma Ornithine transcarbamoylase deficiency Arrhythmia Splenic marginal zone lymphoma Anti-HLA antibody test positive Acute leukaemia Erdheim-Chester disease Candida infection Autoimmune demyelinating disease Immune-mediated myositis More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Treatment Epidermolysis bullosa – Trials in Disease Activated PI3 kinase delta syndrome – Treatment Crigler-Najjar syndrome – Treatment Cholangitis sclerosing – Life with Disease Stevens-Johnson syndrome – Treatment Haemophilia B with anti factor IX – Treatment Isodicentric chromosome 15 syndrome Phenylketonuria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Levothyroxine Lorundrostat Amiloride Hydrochloride Sodium Acetate Trihydrate Calcium Carbonate Codeine Phosphate Cft1946 Aluminium Oxide, Hydrated Niraparib Ponesimod Lanifibranor Ozanimod Finasteride Pyruvic Acid Lysine Hydrochloride Domperidone Elvn-002-1 Thiamine Nitrate Oxcarbazepine Nirmatrelvir More therapies…

    Learn about Your Condition

    Fabry's disease Pulmonary embolism Viral myocarditis Venous thrombosis limb Plasma cell leukaemia Oesophageal adenocarcinoma Ovarian cancer recurrent Epilepsy Medulloblastoma Compulsive sexual behaviour Inflammation Obstructive pancreatitis Double hit lymphoma Type 2 diabetes mellitus Cerebrovascular accident More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mnzxon Zrjngkbl Kcunl 2ys Dvhyebext 4zwtk Hqdrzno

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Omalizumab
    Bulgaria Hungary Latvia Lithuania Poland Slovakia

  • Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Nemolizumab
    Austria Belgium Bulgaria Czechia Estonia France +8

  • Study of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Vascular Endothelial Growth Factor Receptor 3 Extracellular Domains 1-3 Fused To A Igg1 Fc Fragment
    • Aflibercept
    Austria Bulgaria Croatia Czechia Estonia France +10

  • Study on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Bi 1819479
    Austria Belgium Czechia Denmark Finland France +8

  • Study on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Sonelokimab
    Austria Bulgaria Germany Hungary Italy Norway +2

  • Long-term safety study of filgotinib tablets in adults with ulcerative colitis who completed previous filgotinib treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Filgotinib
    Hungary

  • Study of iptacopan effectiveness in achieving remission in patients with active ANCA-associated vasculitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Microscopic polyangiitis
    • Granulomatosis with polyangiitis
    Investigated Drugs:
    • Iptacopan
    Austria Belgium Czechia Denmark France Germany +3

  • Study on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Dry eye
    • Rheumatoid arthritis
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Emtricitabine
    Czechia Germany Hungary Italy The Netherlands Poland +1

  • Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

    Not recruiting

    3 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    • Bi 1015550
    Austria Belgium Croatia Czechia Denmark Estonia +13

  • Study Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Essential thrombocythaemia
    Investigated Drugs:
    • Bomedemstat
    • Hydroxycarbamide
    Austria Denmark France Germany Hungary Italy +3
Previous Page
1 … 30 31 32 33 34 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!